Abel Hall LLC
AVXL icon

Abel Hall LLC’s Anavex Life Sciences AVXL Stock Holding History

Abel Hall LLC’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.9K Sell
10,324
-46,508
-82% -$129K ﹤0.01% 872
2026
Q2 		$147K Buy
+56,832
New +$168K 0.03% 793

Other funds holding AVXL

Apella Capital
Apella Capital West Hartford, Connecticut $7.88B AUM 10.78% 1-Year Est. Return
PVG Asset Management
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
Hikari Power
Hikari Power Tokyo, Japan $439M AUM 11.38% 1-Year Est. Return
LexAurum Advisors
LexAurum Advisors Overland Park, Kansas $893M AUM
Sheets Smith Wealth Management
Sheets Smith Wealth Management Winston-Salem, North Carolina $958M AUM 21.88% 1-Year Est. Return
Opus Capital Group
Opus Capital Group Cincinnati, Ohio $1.02B AUM 13.75% 1-Year Est. Return
Forum Financial Management
Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return
VestGen Advisors
VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Abel Hall LLC's AVXL Position: Q3 2026 in Review

Abel Hall LLC reduced its Anavex Life Sciences (AVXL) stake by 82% in Q3 2026, selling an estimated $129K and leaving 10,324 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #872.

Abel Hall LLC first reported a position in AVXL in Q2 2026 and has held it in 2 quarters since. The position peaked at $147K in Q2 2026. 43 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.

  • Abel Hall LLC held 10,324 shares of Anavex Life Sciences worth $20.9K as of Q3 2026.
  • Abel Hall LLC sold 46,508 Anavex Life Sciences shares in Q3 2026, an estimated $129K.
  • Anavex Life Sciences made up ﹤0.01% of Abel Hall LLC's portfolio in Q3 2026, its #872 holding.
  • Abel Hall LLC first reported a position in Anavex Life Sciences in Q2 2026 and has held it in 2 quarters since.
  • Abel Hall LLC's Anavex Life Sciences position peaked at $147K in Q2 2026.
  • 43 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.